Advocacy intelligence hub — real-time data for patient organizations
Novartis Pharmaceuticals — PHASE3
Leiden University Medical Center — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Primary membranoproliferative glomerulonephritis news →
Marina Noris, PhD
Istituto Di Ricerche Farmacologiche Mario Negri
Fernando C Fervenza, MD, M.D
Mayo Clinic
📍 ROCHESTER, MN
Gerald B Appel, MD, M.D
Columbia University
📍 NEW YORK, NY
Dr. Y.K.O. Teng, MD, PhD
Leiden University Medical Center
Diana Karpman
Region Skåne
John J. Dillon, M.D., M.S.
Mayo Clinic
View all Primary membranoproliferative glomerulonephritis specialists →